Alembic Pharmaceuticals Limited et al v. GlaxoSmithKline LLC et al > Summary
Court Case Number 1:18-cv-01513
Filing Date Sep 28, 2018
Termination Date Nov 27, 2018
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Plaintiff Attorneys
3Alembic Pharmaceuticals, Inc.
Attorney Name: Steven M. Coyle
Cantor Colburn
Alembic Pharmaceuticals, Inc.
Attorney Name: Nicholas A. Geiger
Cantor Colburn
Defendant Attorneys
GlaxoSmithKline
Attorney Name: Brian E. Farnan
Farnan LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09144547 | Oral dosage form for controlled drug release | Sep 29, 2015 |
08637512 | Formulations and method of treatment | Jan 28, 2014 |